Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Pediatric Hematology & Oncology Physician in Boston, MA
NPI: 1225096456Primary Practice Location
BOSTON CHILDREN'S HOSPITAL
300 Longwood Ave, Boston, MA
Primary Employer
Children's Hospital Pediatric Associates, Inc
childrenshospital.org
HQ Phone
Get M.D. Suneet's Phone Numberphone_androidMobile
Get M.D. Suneet's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
MA State Medical License
2005 - 2026
American Board of Pediatrics
Pediatric Hematology-Oncology
Boston Children’s Hospital/Boston Medical Center
Fellowship • Pediatric Hematology/Oncology
2003 - 2006
Residency • Pediatrics
2001 - 2003
Harvard Medical School
hms.harvard.edu
Medical School
Until 2001
Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem Cells.
Authors: Robert Lindsley, Daniel Bauer, Sioban Keel, Lauri Burroughs
Publication Date: 2019-11-01
Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem Cells
Deletion of a conserved Il4 silencer impairs T helper type 1–mediated immunity
Authors: K. Mark Ansel, Rebecca J. Greenwald, Suneet Agarwal, Craig H. Bassing, Silvia Monticelli, Jeneen Interlandi, Ivana M. Djuretic, Dong U. Lee, Arlene H. Sharpe, Frederick W. Alt, Anjana Rao
Publication Date: 2004-10
Lead Sponsor: Boston Children's Hospital
Collaborators: Children's Hospital Los Angeles, Mayo Clinic, Children's Hospital of Philadelphia, Massachusetts General Hospital, University of Chicago, Children's Hospital Medical Center, Cincinnati, Duke University, Dana-Farber Cancer Institute, Children's Mercy Hospital Kansas City, Baylor College of Medicine, University of Wisconsin, Madison, Karolinska University Hospital, Oslo University Hospital, Hackensack Meridian Health, Fred Hutch/University of Washington/Seattle Children's Cancer Consortium
Intervention / Treatment: BIOLOGICAL: alemtuzumab, DRUG: Tacrolimus, DRUG: Fludarabine, DRUG: Mycophenolate mofetil, DRUG: Cyclosporins
